Application of laser spectroscopy for measurement of exhaled ethane in patients with lung cancer.

There is increasing interest in ethane (C(2)H(6)) in exhaled breath as a non-invasive marker of oxidative stress (OS) and thereby a potential indicator of disease. However, the lack of real-time measurement techniques has limited progress in the field. Here we report on a novel Tunable Diode Laser Spectrometer (TDLS) applied to the analysis of exhaled ethane in patients with lung cancer. The patient group (n=52) comprised randomly selected patients presenting at a respiratory clinic. Of these, a sub-group (n=12) was subsequently diagnosed with lung cancer. An age-matched group (n=12) corresponding to the lung cancer group was taken from a larger control group of healthy adults (n=58). The concentration of ethane in a single exhaled breath sample collected from all subjects was later measured using the TDLS. This technique is capable of real-time analysis of samples with accuracy 0.1 parts per billion (ppb), over 10 times less than typical ambient levels in the northern hemisphere. After correcting for ambient background, ethane in the control group (26% smokers) ranged from 0 to 10.54 ppb (median of 1.9 ppb) while ethane in the lung cancer patients (42% smokers) ranged from 0 to 7.6 ppb (median of 0.7 ppb). Ethane among the non-lung cancer patients presenting for investigation of respiratory disease ranged from 0 to 25 ppb (median 1.45 ppb). We conclude that, while the TDLS proved effective for accurate and rapid sample analysis, there was no significant difference in exhaled ethane among any of the subject groups. Comments are made on the suitability of the technique for monitoring applications.

[1]  W. Cheng,et al.  Technology development in breath microanalysis for clinical diagnosis. , 1999, The Journal of laboratory and clinical medicine.

[2]  S. Erzurum,et al.  Differential expression of manganese superoxide dismutase and catalase in lung cancer. , 2001, Cancer research.

[3]  Miles J Padgett,et al.  Development of high-resolution real-time sub-ppb ethane spectroscopy and some pilot studies in life science. , 2005, Applied optics.

[4]  T. Ludden,et al.  Metabolism of ethane and pentane to carbon dioxide by the rat. , 1988, Drug metabolism and disposition: the biological fate of chemicals.

[5]  Graham M. Gibson,et al.  A field-portable, laser-diode spectrometer for the ultra-sensitive detection of hydrocarbon gases , 2002 .

[6]  D. Nowak,et al.  Enhanced lipid peroxidation in cancer tissue homogenates in non-small cell lung cancer. , 2001, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[7]  M. Lieberman,et al.  Ethane Evolution: A New Index of Lipid Peroxidation , 1974, Science.

[8]  A. Glidle,et al.  Current and future uses of breath analysis as a diagnostic tool , 2004, Veterinary Record.

[9]  P. Hering,et al.  Real-time monitoring of ethane in human breath using mid-infrared cavity leak-out spectroscopy , 2001 .

[10]  P. Barnes,et al.  Elevation of exhaled ethane concentration in asthma. , 2000, American journal of respiratory and critical care medicine.

[11]  Jean-Charles Preiser,et al.  Antioxidant therapy in intensive care , 2003, Current opinion in critical care.

[12]  Kevin Gleeson,et al.  Detection of lung cancer with volatile markers in the breath. , 2003, Chest.

[13]  H. Sies,et al.  1 – Oxidative Stress: Introductory Remarks , 1985 .

[14]  D. Nowak,et al.  Comparison of hydrogen peroxide generation and the content of lipid peroxidation products in lung cancer tissue and pulmonary parenchyma. , 2000, Respiratory medicine.

[15]  Magdi H. Yacoub,et al.  Disease Markers in Exhaled Breath , 2002 .

[16]  Daniel Halmer,et al.  Parts per trillion sensitivity for ethane in air with an optical parametric oscillator cavity leak-out spectrometer. , 2004, Optics letters.

[17]  J. Allard,et al.  Breath alkanes as a marker of oxidative stress in different clinical conditions. , 2000, Free radical biology & medicine.

[18]  T. Risby,et al.  Clinical application of breath biomarkers of oxidative stress status. , 1999, Free radical biology & medicine.

[19]  P. Shah,et al.  Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction. , 2000, American journal of respiratory and critical care medicine.

[20]  J. Pierce,et al.  Oxidative stress in critically ill patients. , 2002, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[21]  S. Ward,et al.  Effect of maximal dynamic exercise on exhaled ethane and carbon monoxide levels in human, equine, and canine athletes. , 2005, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[22]  H. J. O’neill,et al.  Volatile organic compounds in exhaled air from patients with lung cancer. , 1985, Clinical chemistry.

[23]  A. V. Van rij,et al.  In vivo lipid peroxidation in man as measured by the respiratory excretion of ethane, pentane, and other low-molecular-weight hydrocarbons. , 1985, Analytical biochemistry.